Dow Up 1.31% Nasdaq Up 2.40%

EnteroMedics Inc. (ETRM)

-NasdaqCM
1.14 Up 0.11(10.68%) 4:00PM EDT
Prev Close:1.03
Open:1.04
Bid:N/A
Ask:2.20 x 500
1y Target Est:4.60
Beta:1.63
Earnings Date:Oct 29 - Nov 3 (Est.)
Day's Range:1.02 - 1.15
52wk Range:0.99 - 2.66
Volume:617,229
Avg Vol (3m):1,228,510
Market Cap:78.53M
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ETRM

Comparison

Symbol% ChgMkt Cap
ETRMUp 10.68%78.53M
ABTUp 2.24%63.74B
MDTUp 1.79%63.65B
RHHBYUp 1.51%247.27B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.39
Quarterly EPS Est (Sep-14) :-0.10
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):0.32

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

EnteroMedics Inc., a development stage medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback